CINECA IRIS Institutional Research Information System

ZOLA, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.663
EU - Europa 4.353
AS - Asia 2.877
SA - Sud America 120
AF - Africa 71
OC - Oceania 46
Continente sconosciuto - Info sul continente non disponibili 12
Totale 12.142
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.508
CN - Cina 1.471
IT - Italia 815
IE - Irlanda 607
DE - Germania 513
FR - Francia 434
UA - Ucraina 409
SG - Singapore 373
FI - Finlandia 360
KR - Corea 340
GB - Regno Unito 297
SE - Svezia 294
IN - India 169
PL - Polonia 163
JP - Giappone 143
AT - Austria 129
VN - Vietnam 119
CA - Canada 99
ES - Italia 61
ID - Indonesia 57
BR - Brasile 56
NL - Olanda 55
MX - Messico 48
AU - Australia 43
TH - Thailandia 41
BE - Belgio 34
TR - Turchia 31
GR - Grecia 29
CH - Svizzera 26
IR - Iran 25
RU - Federazione Russa 23
HK - Hong Kong 22
AR - Argentina 20
MY - Malesia 19
EG - Egitto 18
BA - Bosnia-Erzegovina 17
RO - Romania 16
TW - Taiwan 16
IL - Israele 12
PE - Perù 11
PT - Portogallo 11
BD - Bangladesh 10
DK - Danimarca 10
VE - Venezuela 10
CO - Colombia 8
CZ - Repubblica Ceca 8
EU - Europa 8
EC - Ecuador 7
HU - Ungheria 7
NO - Norvegia 7
ZA - Sudafrica 7
CL - Cile 6
SA - Arabia Saudita 6
SI - Slovenia 6
SN - Senegal 6
HR - Croazia 5
MW - Malawi 5
NG - Nigeria 5
PH - Filippine 5
RS - Serbia 5
AP - ???statistics.table.value.countryCode.AP??? 4
BG - Bulgaria 4
BY - Bielorussia 4
TZ - Tanzania 4
ET - Etiopia 3
GH - Ghana 3
KE - Kenya 3
MU - Mauritius 3
NP - Nepal 3
PK - Pakistan 3
PR - Porto Rico 3
UG - Uganda 3
DZ - Algeria 2
GT - Guatemala 2
IQ - Iraq 2
MM - Myanmar 2
NZ - Nuova Zelanda 2
TN - Tunisia 2
UZ - Uzbekistan 2
ZM - Zambia 2
AL - Albania 1
BO - Bolivia 1
BW - Botswana 1
DO - Repubblica Dominicana 1
FJ - Figi 1
HT - Haiti 1
JO - Giordania 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
MA - Marocco 1
ME - Montenegro 1
MK - Macedonia 1
MN - Mongolia 1
PA - Panama 1
QA - Qatar 1
RE - Reunion 1
RW - Ruanda 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 12.141
Salva come PNG Salva come JPEG
Città #
Beijing 872
Dublin 603
Chandler 464
Singapore 281
Houston 252
Jacksonville 251
Villeurbanne 238
Medford 211
Princeton 186
Fairfield 184
Wilmington 164
Milan 153
Torino 148
Warsaw 144
Ann Arbor 143
Ashburn 139
Vienna 122
Redwood City 116
Woodbridge 111
Nyköping 96
Boston 84
Seattle 79
Dearborn 74
Cambridge 71
Verona 66
Pisa 60
Dong Ket 57
Shanghai 53
Guangzhou 48
Santa Clara 45
Nanjing 43
Norwalk 39
Fremont 36
Rome 32
Jakarta 31
Lachine 30
Turin 29
Hangzhou 28
Hefei 28
Wuhan 28
Seoul 27
Tokyo 27
Detroit 26
Boardman 25
Los Angeles 25
Zhengzhou 24
Toronto 23
Falls Church 21
Hebei 21
New York 21
Shenyang 21
Brussels 18
Kunming 18
Phoenix 18
Jinan 17
Rochester 17
Athens 15
Paris 15
San Diego 15
Changsha 14
Delhi 14
Leiden 14
London 14
Buenos Aires 13
Nanchang 13
Chicago 12
Fuzhou 12
Helsinki 12
New Delhi 12
Berlin 11
Chengdu 11
Xian 11
Bangkok 10
Barcelona 10
Buffalo 10
Central District 10
Changchun 10
Nanning 10
Nürnberg 10
Taipei 10
Bengaluru 9
Lima 9
Madrid 9
Mountain View 9
Silver Spring 9
Bugojno 8
Chongqing 8
Hanoi 8
Pune 8
Tianjin 8
Amsterdam 7
Baltimore 7
Bern 7
Brescia 7
Chennai 7
Düsseldorf 7
Heraklion 7
Magé 7
Mexico 7
Moscow 7
Totale 6.631
Salva come PNG Salva come JPEG
Nome #
Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. 1.223
The Role of HE4 in Ovarian Cancer Follow-up: A Review. 642
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. 362
Advanced ovarian cancer: phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel vs carboplatin-paclitaxel. 335
Relationship between time interval from primary surgery to the start of taxane- plus platinum-based chemotherapy and clinical outcome of patients with advanced epithelial ovarian cancer: results of a multicenter retrospective Italian study 213
Adjuvant treatment and analysis of failures in patients with high-risk FIGO Stage Ib-II endometrial cancer: an Italian multicenter retrospective study (CTF study). 211
Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies. 171
Neoadjuvant platinum-based chemotherapy followed by radical hysterectomy for stage Ib2-IIb adenocarcinoma of the uterine cervix – An Italian multicenter retrospective study 159
Malattie del Gestotrofoblasto Cap.28 150
Is carboplatin-paclitaxel combination the standard treatment of elderly ovarian cancer patients? 147
Is Ovarian Cancer Being Managed According to Clinical Guidelines? Evidence from a Population-Based Clinical Audit 126
The role of the French-Italian glossary of complications in the outcome evaluation of cervical cancer treatment: an Italian multicentric study. 125
Missing data in longitudinal studies: Comparison of multiple imputation methods in a real clinical setting 124
Pretreatment serum hemoglobin level and a preliminary investigation of intratumoral microvessel density in advanced ovarian cancer 120
Il follow-up del carcinoma dell'ovaio:implicazione di nuovi dati d'efficenza 118
A proposed glossary of terminology related to the surgical treatment of vulvar carcinoma. 117
A search for predictive factors for hypersensitivity reactions to taxanes and platinum salts in chemotherapy for gynecologic pelvic neoplasm? 112
Pretreatment serum hemoglobin level as a predictive factor of response to neoadjuvant chemotherapy in patients with locally advanced squamous cervical carcinoma: a preliminary report 109
A randomized comparison of high dose epirubicin versus high dose epirubicin plus lonidamine in advanced breast cancer patients. First results from a cooperative group study 99
CO2 laser vaporization for the treatment of vaginal intraepithelial neoplasia: effectiveness and predictive factors for recurrence 99
Intratumoral microvessel density in advanced epithelial ovarian cancer and its use as a prognostic variable 95
Angiogenesis and molecular markers in advanced epithelial ovarian cancer: A retrospective study 94
Analysis of vitamin D receptor expression and clinical correlations in patients with ovarian cancer 89
Diagnostic Accuracy And Cost-Effectiveness Of Different Strategies To Triage Adnexal Masses: A Prospective Study 88
Missing data imputation in longitudinal trial of endometrial cancer patients 85
A simplified fascial model of pelvic anatomical surgery: going beyond parametrium-centered surgical anatomy 84
[Anatomo-pathological verification of dosimetry using a calculator in curietherapy of cancer of the cervix uteri] 81
Treatment of early cervical cancer:survival, complications and economical aspects 81
Classification of complications in gynecological malignancies treatments 74
Infertility as a negative prognostic factor in endometrial cancer: analysis in 357 patients treated at the university hospital of Turin 74
Phase II trial with 5-fluorouracil and high-dose folinic acid, using new sequential dosing schedule, in pretreated advanced breast cancer patients. 73
Analysis of complications of cervix carcinoma treated by radiotherapy using the Franco-Italian glossary. 72
QUALITY OF LIFE AND URINARY FUNCTION AFTER RADICAL VULVECTOMY WITH OR WITHOUT FLAP REPAIR 70
INTEGRATED TREATMENT IN CERVICAL CANCER: COSTS AND BENEFITS 70
Economic considerations on the follow-up practice in gynecologic cancers: Few lights and many shadows from a literature review 70
Attitudes of Italian gynaecologists towards prophylactic oophorectomy at hysterectomy for non-malignant conditions 69
Daily administration of low molecular weight heparin increases Hepatocyte Growth Factor serum levels in gynaecological patients: pharmacokinetic parameters and clinical implications. 69
Frequenza e fattori predittivi di reazioni acute da ipersensibilità in pazienti chemiotrattate per neoplasie ginecologiche pelviche (studio preliminare) 69
Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study. 67
[The use of aminoglutethimide in the treatment of metastatic breast cancer] 66
Prognostic value of lymph node status and number of removed nodes in patients with squamous cell carcinoma of the vulva treated with modified radical vulvectomy and inguinal-femoral lymphadenectomy. 66
Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status 66
A glossary for reporting complications of treatment in gynecological cancers. 64
Interleukin-3 in vivo: kinetic of response of target cells. 63
Modified radical hysterectomy versus extrafascial hysterectomy in the treatment of stage I endometrial cancer:results from the ILIADE randomized study 63
Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapy. 62
[Follow-up in a patient treated for carcinoma of the breast] 62
Uterine leiomyosarcoma: analysis of treatment failures and survival. 62
An analysis of approaches to the treatment of endometrial cancer in western Europe: a CTF study. 62
The need for accredited training in gynaecological oncology: a report from the European Network of Young Gynaecological Oncologists (ENYGO). 62
Follow-up in gynecological malignancies: A state of art 62
An analysis of different approaches to ovarian cysts in Italy 61
An analysis of approaches to the management of endometrial cancer in North America: a CTF study. 60
Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial 60
PATTERN OF FAILURES AND PROGNOSTIC FACTORS IN TYPE 2 ENDOMETRIAL CARCINOMA: A SINGLE INSTITUTION RETROSPECTIVE STUDY 60
Aggressive clinical course of primary invasive vaginal carcinoma associated with HPV type 61: a case report. 60
A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study 60
Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial 60
Different types of hysterectomy in the radio-surgical treatment of early cervical cancer (FIGO Ib-IIa). 58
Predictive factors for first recurrence of vaginal intraepithelial neoplasia after treatment with co2-laser vaporization 58
Complications after the treatment of endometrial cancer: a prospective study using the French-italian glossary. 58
Prognostic and predictive value of combined HE-4 and CA-125 biomarkers during chemotherapy in patients with epithelial ovarian cancer 58
Analysis of failures after negative second-look in patients with advanced ovarian cancer: an Italian multicenter study. 57
Pre-chemotherapy hemoglobin levels and survival in patients with advanced epithelial ovarian cancer who received a first-line taxane/platinum-based regimen: results of a multicenter retrospective Italian study 56
Chemotherapy plus radiation in advanced-stage endometrial cancer. 56
Pathological response on surgical samples is an independent prognostic variable for patients with Stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: an Italian multicenter retrospective study (CTF Study). 55
Analysis of the evolution in the management of endometrial cancer in Italy: a CTF study. 54
Integrated treatment in cervical cancer: costs and benefits 54
Impact of cancer in the management of delivery: 10 years of variations 54
Ectopic production of prostate specific antigen by a breast tumor metastatic to the ovary. 53
Training in bowel and upper abdominal surgery in gynaecological oncology: European Society of Gynecological Oncology (ESGO) Statement 53
Transvaginal sonography in the diagnosis of pelvic malignant recurrence: integration of sonography and needle-guided biopsy. 53
Radiosurgical treatment of uterine cervix carcinoma at the 1st Clinic of Obstetrics and Gynecology of the University of Turin, (in the period 1972-1978). 52
Analysis of Treatment Failures and Survival of Patients With Uterine Papillary SerousCarcinoma: A Cooperation Task Force (CTF) Study. 52
Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian multicenter retrospective analysis. 52
[The tumorectomy-TCT-interstitial curietherapy in the treatment of breast cancers in the initial phase] 51
Phase I/II study with pegylated liposomal doxorubicin and prolonged infusion gemcitabine in recurrent ovarian cancer 51
Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group. 51
[Conservative treatment of carcinoma of the breast] 50
Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trial. 50
[Crohn's disease with acute presentation in pregnancy] 49
[Histologic findings following curietherapy in cervical cancer. A study of surgically excised tissues (author's transl)] 49
ESGO statement on the role of CA-125 measurement in follow-up of epithelial ovarian cancer. 49
GnRH agonists and antiestrogens in the management of breast cancer. 49
Localization and management of occult breast lesions. 49
Ultrasound and clinical characteristics of uterine smooth muscle tumors of uncertain malignant potential (STUMPs) 48
[Survival and recurrence of endometrial adenocarcinoma] 47
Clinicopathologic prognostic factors in endometrial cancer: a multivariate analysis in 357 patients 47
Follow-up criteria: background and procedures. 47
The relationship between postoperative decline of serum CA 125 levels and size of residual disease after initial surgery in patients with advanced ovarian cancer: a CTF study. 46
Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature 46
Overexpression of the Met/HGF receptor in ovarian cancer. 46
Critères du suivi des cancers gynécologiques : situation actuelle et procédures. 46
Feasibility of laparoscopy for women with ovarian cysts: how many spillages? 46
Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy 46
Prognostic value of estrogen receptors determined by radiochemical vs. histochemical methods in breast cancer. 45
[Usefulness of a 2d laparotomy and laparoscopy in the follow-up of patients receiving ovarian tumor therapy] 45
Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study. 45
[Occult mammary lesions: preoperative localization. Review of the literature] 45
Comorbility in endometrial cancer treated patients: risk factors or prognostic factors? 45
Totale 9.538
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.778
article - articoli 0
book - libri 0
conference - conferenze 4.319
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.097
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.405 0 0 0 174 176 219 225 104 194 149 118 46
2020/20211.268 125 87 167 73 97 77 121 44 170 95 47 165
2021/20221.399 60 72 49 87 71 46 93 99 43 106 266 407
2022/20231.995 210 61 59 120 186 611 200 164 196 43 96 49
2023/20241.035 108 176 85 73 67 93 62 58 20 45 66 182
2024/2025383 38 178 84 83 0 0 0 0 0 0 0 0
Totale 12.635